序贯调节Wnt/β-catenin信号通路增强肿瘤内在MHC I表达并促进肿瘤清除
本研究利用人肿瘤样本、患者来源异种移植模型和同系小鼠模型,单独或序贯给予Wnt/β-catenin调节剂DKN-01和CGX-1321。DKN-01阻断DKK1后HLA/MHC表达增加,CGX-1321抑制PORCN后CXCL10产生增多;序贯联合降低肿瘤负荷(大网膜重量减少),为卵巢肿瘤免疫治疗提供可能。
要点
- DKN-01阻断DKK1可增加人和小鼠组织HLA/MHC表达。
- CGX-1321抑制PORCN增加T细胞趋化因子CXCL10产生。
- 序贯DKK1阻断和PORCN抑制可减少大网膜重量、降低肿瘤负荷。
核心结论
- Wnt/β-catenin通路调节增加MHC I表达并促进肿瘤白细胞浸润,形成促免疫肿瘤微环境,与肿瘤负荷降低相关。
- 该干预克服常见肿瘤免疫逃逸机制,可能使卵巢肿瘤对免疫治疗敏感。
研究设计与样本
- 研究使用人肿瘤样本、体内患者来源异种移植模型和同系小鼠模型。
- 模型单独或序贯给予Wnt/β-catenin调节剂DKN-01和CGX-1321。
- 分析方法包括免疫组化、流式细胞术、多重细胞因子/趋化因子阵列和RNA测序。
主要发现
- DKN-01阻断DKK1后,人和小鼠组织HLA/MHC表达增加,与已知MHC I调节因子NFkB、IL-1、LPS和IFNγ表达升高相关。
- CGX-1321抑制PORCN后,T细胞趋化因子CXCL10产生增加,为观察到的瘤内T细胞增加提供机制。
- 观察到多种白细胞募集,B细胞和巨噬细胞升高,肿瘤中群体特异性趋化因子表达增加。
- 序贯DKK1阻断和PORCN抑制降低肿瘤负荷,表现为大网膜重量减少。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Progress in immunotherapy use for gynecologic malignancies is hampered by poor tumor antigenicity and weak T cell infiltration of the tumor microenvironment (TME). Wnt/β-catenin pathway modulation demonstrated patient benefit in clinical trials as well as enhanced immune cell recruitment in preclinical studies. The purpose of this study was to characterize the pathways by which Wnt/β-catenin modulation facilitates a more immunotherapy-favorable TME. METHODS: Human tumor samples and in vivo patient-derived xenograft and syngeneic murine models were administered Wnt/β-catenin modulating agents DKN-01 and CGX-1321 individually or in sequence. Analytical methods included immunohistochemistry, flow cytometry, multiplex cytokine/chemokine array, and RNA sequencing. RESULTS: DKK1 blockade via DKN-01 increased HLA/MHC expression in human and murine tissues, correlating with heightened expression of known MHC I regulators: NFkB, IL-1, LPS, and IFNy. PORCN inhibition via CGX-1321 increased production of T cell chemoattractant CXCL10, providing a mechanism for observed increases in intra-tumoral T cells. Diverse leukocyte recruitment was noted with elevations in B cells and macrophages, with increased tumor expression of population-specific chemokines. Sequential DKK1 blockade and PORCN inhibition decreased tumor burden as evidenced by reduced omental weights. CONCLUSIONS: Wnt/β-catenin pathway modulation increases MHC I expression and promotes tumor leukocytic infiltration, facilitating a pro-immune TME associated with decreased tumor burden. This intervention overcomes common tumor immune-evasion mechanisms and may render ovarian tumors susceptible to immunotherapy.
引用
- Dholakia J, Scalise CB, Katre AA, et al. Sequential modulation of the Wnt/β-catenin signaling pathway enhances tumor-intrinsic MHC I expression and tumor clearance. Gynecol Oncol. 2021. PMID: 34844776. doi:10.1016/j.ygyno.2021.09.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。